Related Experiment Videos
[Hepatic artery embolization for primary hepatic carcinoma]
1First Hospital, Sun Yat-sen University of Medical Sciences, Guangzhou.
Zhonghua Zhong Liu Za Zhi [Chinese Journal of Oncology]
|March 1, 1989
Summary
Hepatic arterial embolization offers a safe and effective treatment for primary hepatic carcinoma (PHC), improving patient symptoms and potentially increasing resectability. This method is suitable for patients with compensated liver function and a patent portal system.
Area of Science:
- Interventional Radiology
- Oncology
- Hepatology
Context:
- Primary hepatic carcinoma (PHC) presents a significant clinical challenge.
- Hepatic arterial embolization (HAE) is an emerging therapeutic modality.
Purpose:
- To evaluate the safety and efficacy of HAE combined with chemotherapy for PHC.
- To assess patient outcomes, including symptom relief, tumor response, and complications.
Summary:
- Twenty PHC patients underwent HAE using chemotherapeutic agents and embolic materials.
- Most patients experienced symptom improvement, with two achieving total tumor necrosis post-surgery.
- Mild side effects were manageable; three patients died from renal failure, but no severe HAE-related complications occurred.
Impact:
- HAE is a viable treatment option for PHC patients with compensated liver function and patent portal systems.
- This therapy can improve resectability and serve as palliative care for advanced cases.
- HAE demonstrates potential as a safe and effective treatment in managing PHC.